Raise Money for Head and Neck Cancer Treatment

PavelAndreev.ORG is an international crowdfunding platform for raising donations, through which thousands of charitable online campaigns have been organized. The platform is free for anyone who wants to start a campaign.

Start a campaign

How to start a head and neck cancer treatment fundraiser?

Your fundraiser on PavelAndreev.ORG starts in three quick and easy steps:

Create a campaign

Start your head and neck cancer treatment fundraising campaign in minutes by following the platform's steps and instructions.

Admin review & support

A platform administrator will review your head and neck cancer treatment campaign and help you prepare it in the best possible way.

Share & launch

Share your head and neck cancer treatment fundraising campaign on social media and receive donations from people who care.

Create a campaign

Start your head and neck cancer treatment fundraising campaign in minutes by following the platform's steps and instructions.

Admin review & support

A platform administrator will review your head and neck cancer treatment campaign and help you prepare it in the best possible way.

Share & launch

Share your head and neck cancer treatment fundraising campaign on social media and receive donations from people who care.

Start a campaign

Types of medical costs in head and neck cancer treatment

  • Diagnostic and Staging Workup Costs: Expenses for clinical examinations, endoscopic procedures (fiberoptic endoscopy, examination under anesthesia), diagnostic imaging (contrast-enhanced CT, MRI of the primary site/neck/skull base, and FDG PET/CT), tissue biopsies (fine-needle aspiration, core/incisional biopsy), and molecular or biomarker testing (p16/HPV immunohistochemistry, PD-L1 CPS scoring, and EBV DNA profiling).
  • Surgical Procedure Costs: Operating room utilization, surgical team professional fees, and anesthesia for primary tumor resections (open, transoral robotic surgery [TORS], transoral laser microsurgery [TLM]), neck dissections (selective, modified, radical), and microvascular free-flap tissue reconstructions.
  • Radiation Therapy Delivery Costs: Treatment planning, dosimetric contouring, target volume delineation (GTV, CTV, PTV), quality assurance, daily fractionated external beam radiation therapy (EBRT), intensity-modulated radiation therapy (IMRT), intensity-modulated proton therapy (IMPT), and reirradiation planning.
  • Systemic Therapy and Pharmacotherapy Costs: Drug acquisition and administration costs for cytotoxic chemotherapy (cisplatin, carboplatin, 5-FU, gemcitabine, docetaxel, paclitaxel), targeted monoclonal antibodies (cetuximab), immune checkpoint inhibitors (pembrolizumab, nivolumab, toripalimab), bispecific antibodies (amivantamab), and premedications or supportive medications.
  • Hospitalization and Acute Care Costs: Inpatient admission for major surgical recovery, post-procedure observation, inpatient management of severe acute treatment toxicities (such as Grade 3/4 mucositis or neutropenia), and day-care infusion center facility utilization.

  • Pre-Treatment and Prehabilitation Costs: Baseline multidisciplinary evaluations, pre-anesthesia medical workup, baseline dental and prosthodontic clearance (including extractions prior to radiation), baseline speech, swallowing, and audiology testing, and dietary counseling.
  • Neoadjuvant and Induction Therapy Costs: Short-course induction chemotherapy or neoadjuvant immunotherapy regimens delivered prior to primary definitive surgical or radiation intervention.
  • Primary Definitive Treatment Costs: Definitive single-modality or combined-modality interventions, including primary resection, definitive radiation therapy, or concurrent chemoradiotherapy.
  • Adjuvant Treatment Costs: Postoperative radiation therapy or concurrent postoperative chemoradiation for patients exhibiting high-risk adverse pathologic features (such as extranodal extension or positive surgical margins).
  • Post-Treatment Surveillance and Follow-up Costs: Post-treatment physical examinations, interval imaging, liquid biopsy monitoring (such as circulating tumor HPV DNA assays), and therapeutic response assessments.
  • Recurrent, Persistent, or Salvage Treatment Costs: Salvage surgical resections, reirradiation protocols, second-line systemic therapies, and compassionate-use schemes for recurrent or progressive disease.

  • Geographic and Center Variation Costs: Cost differences associated with treatment at academic high-volume institutions versus community or rural facilities, regional practice pattern variations in radiation technologies (such as IMRT adoption), and logistical or travel expenses for care in endemic regions versus non-endemic areas.
  • Socioeconomic and Insurance Profile Costs: Administrative overhead related to cashless insurance processing, out-of-pocket costs, patient assistance and financing plans (such as EMI structures), and clinical complexity costs linked to baseline patient comorbidity indices (such as the ACE-27 score).
  • Demographic and Risk Factor Management Costs: Age- and performance-status-adjusted care delivery overhead, race- and sex-associated health service utilization patterns, and lifestyle modification services including formal smoking and alcohol cessation programs.

  • Oral Cavity Cancers: Resection, flap reconstruction, and specialized dental/prosthodontic management for tumors of the lip, buccal mucosa, floor of mouth, anterior tongue, alveolar ridge, retromolar trigone, and hard palate.
  • Oropharyngeal Cancers (HPV-Positive / HPV-Negative): Primary transoral robotic surgery (TORS) versus definitive chemoradiotherapy, de-escalation protocol monitoring, and toxicity mitigation for sites including the tonsil, base of tongue, soft palate, and pharyngeal wall.
  • Laryngeal and Hypopharyngeal Cancers: Larynx-preserving conservation approaches versus total laryngectomy, partial/total laryngopharyngectomy, tracheostomy placement, and functional voice/swallowing rehabilitation.
  • Nasopharyngeal Carcinoma (NPC): Definitive IMRT, concurrent platinum-based chemotherapy, induction/adjuvant chemotherapy protocols, and skull-base MRI/CT imaging overhead.
  • Paranasal Sinus and Salivary Gland Tumors: Maxillary and ethmoid sinus resections, complex parotid or submandibular gland surgery, minor salivary gland management, and histology-specific targeted therapies.
  • Cervical Lymphatics / Neck Dissections: Unilateral or bilateral selective, modified, or radical neck dissections, cervical lymph node staging, and post-surgical neck lymphedema therapy.

  • Advanced Radiation Technologies: High-precision planning and delivery fees for Intensity-Modulated Radiation Therapy (IMRT), Intensity-Modulated Proton Therapy (IMPT), image-guided radiotherapy (IGRT), and hypofractionated schedules.
  • Minimally Invasive Surgical Innovations: Capital and operational costs for Transoral Robotic Surgery (TORS) and Transoral Laser Microsurgery (TLM), including surgeon credentialing and surgical quality assurance systems.
  • Novel Pharmacotherapy and Biomarker Innovations: Targeted therapies (cetuximab), immune checkpoint inhibitors (pembrolizumab, nivolumab), bispecific antibody constructs (amivantamab), and molecular diagnostic panels (PD-L1 CPS, EGFR, EBV DNA).
  • De-intensification and Clinical Protocol Costs: Institutional clinical trial enrollment, protocol-mandated biomarker stratifications (such as circulating HPV DNA profiling), and experimental therapy monitoring.

  • Speech and Swallowing Rehabilitation Costs: Speech-language pathology consultations, prophylactic/rehabilitative pharyngeal strengthening exercises, expiratory muscle strength training, videostroboscopy, and long-term dysphagia therapy.
  • Nutritional Support and Feeding Care Costs: Enteral feeding tube placement (percutaneous endoscopic gastrostomy), enteral formula supplies, oral nutritional supplements, and ongoing dietary monitoring.
  • Dental, Oral, and Bone Complication Care Costs: Treatment of radiation-induced xerostomia, dental extractions, and management of mandibular osteoradionecrosis (ORN) via medical protocols (PENTOCLO: pentoxifylline, tocopherol, clodronate) or surgical mandibulectomy with bone free-flap reconstruction.
  • Physical and Specialized Functional Care Costs: Neck lymphedema therapy, physical medicine and rehabilitation, trismus management, and tracheotomy care including decannulation facilitation.
  • Psychosocial, Audiology, and Survivorship Costs: Psychological distress screening, depression management, clinical social work services, audiology evaluations for radiation/cisplatin-induced hearing loss, and long-term survivorship care plan integration.

  • Multidisciplinary Team Coordination Costs: Operational expenses of multidisciplinary tumor boards involving surgical oncology, radiation oncology, medical oncology, pathology, radiology, specialized nursing, and allied health staff.
  • High-Volume Facility and Quality Assurance Infrastructure: Hospital infrastructure maintenance, surgical quality assurance credentialing, high-volume inpatient ward operations, and ambulatory day-care infusion suites.
  • Radiation Physics and Technical Hardware Overhead: Acquisition, maintenance, and dosimetric quality control of linear accelerators, proton therapy systems, CT simulators, and commercial treatment planning software.
  • Pathology and Diagnostic Laboratory Infrastructure: Specialized cytopathology, immunohistochemistry testing facilities (p16, PD-L1), molecular profiling laboratories, and advanced radiology equipment upkeep.

  • Symptom and Pain Management Costs: Pharmacological pain control (analgesics, adjunctive nerve pain medications like gabapentin) and management of treatment-related toxicities such as severe mucositis and soft tissue ulceration.
  • Palliative Surgical and Interventional Costs: Surgical interventions aimed at symptom relief, including palliative tracheostomy for airway obstruction, gastrostomy for severe aspiration risk, and debridement/reconstruction of necrotic or dysfunctional tissues.
  • Palliative Radiation and Systemic Therapy Costs: Hypofractionated palliative radiation regimens (such as the QUAD SHOT schedule), single-agent palliative systemic therapy, and supportive intravenous infusions.
  • End-of-Life and Hospice Support Costs: Best supportive care services, clinical social work, distress management, case management, and home or facility-based hospice care.

PavelAndreev.ORG results:

Donor trust and the security of funds on the platform are our highest priority. Be proactive. Start successful campaigns and raise donations! With PavelAndreev.ORG you can count on modern methods for receiving donations, a team that will be by your side throughout your campaign, security for your money, and 24/7 access to it.

Total you have donated

49.57M EUR

Regardless of its size, every donation helps save a human life or successfully carry out a social cause.

Total number of donations

1 497 541

The contribution of a large number of people reflects the commitment of our society and contributes to the success of the campaigns.

Number of active campaigns

665

Every campaign is a unique cause and offers an opportunity to bring about positive change in our society.

Be proactive. Start successful campaigns and raise donations! With PavelAndreev.ORG you can count on modern methods for receiving donations, a team that will be by your side throughout your campaign, security for your money, and 24/7 access to it.

Start a campaign

Three important reasons to start a campaign on PavelAndreev.ORG

At PavelAndreev.ORG we use new technologies to let you support fundraising campaigns quickly and easily.

Trust and security

To guarantee the security of funds, we use the most modern and proven service providers.

Easy & convenient donations

The platform supports multiple payment methods, through which people from all over the world can donate to your campaign.

Global audience

PavelAndreev.ORG is an international crowdfunding platform with a global audience of donors who want to support meaningful causes.

Trust and security

To guarantee the security of funds, we use the most modern and proven service providers.

Easy & convenient donations

The platform supports multiple payment methods, through which people from all over the world can donate to your campaign.

Global audience

PavelAndreev.ORG is an international crowdfunding platform with a global audience of donors who want to support meaningful causes.

Cancer statistics in the United States

Start a campaign
Start a campaign

PavelAndreev.ORG is a crowdfunding platform for organizing fundraising donation campaigns to raise money, managed by Foundation Pavel Andreev (UIC: 206678629) with founder and CEO Pavel Andreev. All donations made through the fundraising platform PavelAndreev.ORG are administered by the team of Pavel Andreev and the Foundation Pavel Andreev.

Google News: PavelAndreev.ORG, Pavel Andreev.